The role of uric acid as an independent risk factor in the development of coronary heart disease (CHD) has been questioned as serum urate is related to many of the established etiological risk factors for cardiovascular
Introduction
Raised serum uric acid has been associated with an increased risk of coronary heart disease (CHD). [1] [2] [3] [4] However, hyperuricaemia has also been shown to be associated with many cardiovascular risk factors, in particular hypertension, pre-existing CHD, hyperlipidaemia and the use of antihypertensive treatment. [4] [5] [6] [7] [8] [9] [10] [11] Thus the role of serum uric acid as an independent risk factor for CHD remains uncertain. Although earlier studies suggested uric acid to be an independent risk factor for CHD 1, 2 there is now increasing evidence that the association of hyperuricaemia with CHD events is dependent on the association between uric acid and other cardiovascular risk factors. [3] [4] [5] [6] [8] [9] [10] [11] [12] Several investigators conclude that the association is explained by secondary associations of uric acid with hypertension, diuretic agents and elevated levels of tryglyceride. [3] [4] [5] [6] [8] [9] [10] [11] [12] It has also been postulated that hyperuricaemia may be part of the insulin resistance syndrome. [13] [14] [15] [16] A number of investigators have suggested an independent role of uric acid on the risk of CHD in women but not in men. 12, 17 This paper reviews the role of elevated serum uric acid as an independent risk factor for CHD.
Serum uric acid and coronary heart disease
Ever since Gentler et al reported an association of elevated serum uric acid with myocardial infarction in males in 1951, 1 numerous large epidemiological studies have confirmed a positive association between raised serum uric acid and risk of CHD. [2] [3] [4] [5] [6] [8] [9] [10] [11] [12] 17 The question as to whether high disease which could confound the observed association. This review assesses the role of elevated serum uric acid as an independent role for coronary heart disease.
serum uric acid is (1) an independent risk factor for CHD, (2) a spurious determinant of CHD through confounding, or (3) a marker of degenerative vascular disease, has not been fully elucidated. Hypothesized mechanisms whereby serum uric acid may influence coronary risk include enhanced platelet adhesiveness and aggregation. 18, 19 However there is increasing evidence from large prospective studies that the relation between raised serum uric acid and risk of CHD in men is mediated through other risk factors although it is still uncertain whether the observed relation is related to hypertension, use of antihypertensive drugs, hyperlipidaemia, or whether uric acid may be a marker of advanced arterial disease. In the Evans County, Georgia study of 2530 subjects, the relationship between serum acid and CHD was not significant after adjustment for blood pressure and cardiovascular medication. 5 Several large studies have found the apparent association of uric acid with CHD to be related to diuretic use. 6, 7 The Honolulu Heart Study, a study of over 7000 men, showed no correlation between uric acid and CHD after excluding men on diuretic therapy. The Coronary Drug Project Research Group studying 2789 men aged 30-64 years found the increased risk to be related to use of thiazide diuretics. 6 By contrast the Framingham Study found the relation to be independent of antihypertensive treatment but the relationship was attenuated upon adjustment for other cardiovascular risk factors including blood pressure and cholesterol. 4 The NHANES study 12 and the Chicago Heart Association Detection Project in Industry 8 both found the relation between uric acid and risk of CHD in men to be attenuated after adjustment for a range of other cardiovascular risk factors, but neither of these studies ascertained which factors were responsible for the attenuation. The Social Insurance Institution of Finland Study observed the relationship to be confounded by pre-existing CHD. 9 In the British Regional Heart Study the increased risk of CHD appeared to be largely mediated by the association between hyperuricaemia and serum cholesterol.
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Serum uric acid and cardiovascular risk factors
The possibility that the association between uric acid and risk of CHD is due to confounding is supported by the association between serum urate with many of the established cardiovascular risk factors, in particular obesity, use of antihypertensive treatment, hypertension, hyperlipidaemia and pre-existing CHD. [4] [5] [6] [7] [8] [9] [10] [11] [20] [21] [22] Heavy alcohol intake may also raise serum rate by decreasing renal clearance. 23 Although cigarette smoking is a major risk factor for CHD, many studies have observed inverse relationships between smoking and serum urate levels. 3, 11 Physical activity has shown to be inversely associated with lower urate levels. 7 Although raised urate has shown to be associated with an increased risk of development of diabetes, 24, 25 diabetics have been shown to have significantly lower mean urate concentrations 7,11 which may be due to a high rate of urinary excretion in diabetes. 26 
Serum uric acid and hypertension
Several epidemiological and clinical studies have reported a significant association between hyperuricaemia and hypertension. 4, 5, 7, 27 Hyperuricaemia is a frequent finding in patients with essential hypertension and earlier studies have suggested that hyperuricaemia in hypertensive subjects reflect early renal vascular involvement from hypertensive disease. 27, 28 But several studies have found elevated serum uric acid in hypertensives in the absence of clinical renal disease. 29, 30 It has also been suggested that hyperuricaemia may be induced by antihypertensive treatment therapy. 31 More recent studies have emphasised the role of insulin resistance and adiposity. 11, [13] [14] [15] 28 Insulin resistance may directly increase blood pressure by enhanced tubular reabsorption of sodium 32 or indirectly by enhanced activity of the sympathetic nervous system. 33 In several population studies univariate associations of hyperuricaemia and both systolic and diastolic blood pressure have been observed but these relationships were attenuated after adjusting for BMI suggesting a major role of adiposity in this relationship. 7, 8, 11, 34 There also appears to be no conclusive evidence that raised serum uric acid in hypertensive subjects increases vascular risk or mortality, even when induced by diuretics.
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Serum uric acid and hyperlipidaemia
Many investigators have shown raised serum uric acid to be associated with hyperlipidaemia, in particular hypertriglyceridaemia. 6, 7, 16, 30, 38 Many have observed stronger relationships with triglyceride than with cholesterol and recent investigation has suggested that the relationship between raised urate and raised cholesterol is largely mediated through triglycerides. 11 Little association is reported between urate and high density lipoprotein-cholesterol. 11 It is not clear why hyperuricaemia is associated with a clustering of risk factors but a growing body of evidence suggest that serum uric acid together with increased small dense low density lipoprotein-cholesterol particles may be part of the insulin resistance syndrome. [13] [14] [15] [16] 39, 40 Insulin resistance and hyperinsulinaemia may decrease renal excretion of uric acid independently of obesity and creatinine clearance. 41 A possible mechanism may be that insulin enhances tubular sodium reabsorption, which is accompanied by increased reabsorption of uric acid.
14 Insulin resistance may then be the common factor leading to visceral obesity, hypertension, hypertriglyceridaemia and hyperuricaemia which in turn leads to CHD. However, uric acid has been shown to be associated with triglyceride independent of fasting insulin and obesity 42 suggesting that the mechanism of this association is only partly related to insulin resistance and adiposity.
Serum uric acid is the main end product of purine metabolism. Increased urate production could result from high fat diets, de novo biosynthesis and from the breakdown of tissue nucleic acid. A pure sucrose diet increases both uric acid and triglycerides. 43 Thus an increased lipid metabolism leading to elevated triglycerides may enhance uric acid production. It is therefore possible that the association between serum uric acid and CHD is largely mediated by triglyceride metabolism.
Hyperuricaemia and established CHD
Besides being influenced by other risk factors, serum uric acid may also be a consequence of advanced arterial disease. Uric acid is often raised in subjects with established heart disease. Few studies have examined the relationship in men with and without pre-existing CHD disease and the findings have not been consistent. In the US Coronary Drug Project no association was seen between raised serum uric acid and risk of non-fatal myocardial infarction in men with pre-existing myocardial infarction followed up for 3 years. 6 In the Social Insurance Institution of Finland Study, no association was seen between serum uric acid and risk of cardiovascular mortality in men without known heart disease. 9 In men with known heart disease hyperuricaemia was associated with an increase in cardiovascular mortality. Although the findings were not statistically significant after adjustment for other cardiovascular risk factors including antihypertensive treatment and heart enlargement, there was still a nearly two-fold increase in risk of cardiovascular mortality. Similarly, in the British Regional Heart Study the relationship between serum urate and risk of CHD was only observed after adjustment in men with previous definite myocardial infarction. 11 The findings suggest that the positive relationship observed between serum urate and the risk of major CHD is also related to the increased risk in those with severe underlying atherosclerosis.
Serum uric acid and coronary heart disease in women
Although numerous studies in men have concluded that the relationship between uric acid and CHD is likely to be attributable to hypertension, use of diuretics, hyperlipidaemia or pre-existing CHD, some studies have observed the relationship to be independent of these factors in women. 12, 17 The NHANES study observed serum uric acid to be predictive of CHD mortality in women but not in men even after adjustment for these risk factors but for CHD incidence a weaker association was seen. 12 Among women in the Gothenburg Study 44 and the Framingham Study, 4 serum uric acid was independently associated with all cause mortality but not with CHD incidence. The Finnish study observed an independent relationship with CVD mortality in women with no heart disease in the follow-up period of 12 years but not in the first 5 years. 9 No such association was seen in men. The Chicago Heart Association Detection Project in Industry, a study of over 6000 women aged 35-64, observed an independent relationship between serum uric acid and CHD primarily in women aged 55-64 years, ie, postmenopausal, and suggested that hormonal influences may play a role. 17 The reasons for the sex differences are unclear but it has been suggested that there may be an interaction with sex hormones. 17 Women taking both estrogen and progesterone have shown to have significantly lower uric acid levels than those who had never used them. 45, 46 Postmenopausal women have also been shown to have higher levels of uric acid than did other women. 12, 45 It is possible that elevations in uric acid associated with menopausal changes may be responsible for the association seen with cardiovascular or CHD mortality in women. In the ARIC Study no association was seen between serum uric acid and early measure of atherosclerosis (carotid intimal-medial thickness detected by B-mode ultrasonography) in men or women after adjustment for risk fasctors. 45 Given the weak findings with CHD incidence and the inconsistencies seen between population studies and age groups the evidence for an independent role of serum uric acid in the development of CHD in women is weak.
Conclusion
Raised serum urate is associated with many cardiovascular risk factors including hypertension, obesity, insulin resistance and hyperlipidaemia and established CHD. It also appears that raised serum urate may be an integral part of the cluster of risk factors associated with the insulin resistance syndrome, particularly obesity and raised triglycerides. The evidence suggest that the influence of serum uric acid on CHD is probably explained by secondary associations of uric acid with other established etiological risk factors (hypertension, dyslipidaemia, hyperinsulinaemia, obesity and pre-existing disease). The findings lend little support for an independent role of hyperuricaemia in the development of CHD.
